Published in Am J Pharmacogenomics on January 01, 2005
Cancer drug resistance: an evolving paradigm. Nat Rev Cancer (2013) 6.77
Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae. Genetics (2007) 1.17
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion. Cell Cycle (2013) 1.08
Oxidative stress and DNA methylation in prostate cancer. Obstet Gynecol Int (2010) 1.03
Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation. Oncotarget (2014) 0.98
Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition. BMC Genomics (2014) 0.85
Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells. PLoS One (2013) 0.81
Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view. Chem Soc Rev (2016) 0.80
Similar blood-borne DNA methylation alterations in cancer and inflammatory diseases determined by subpopulation shifts in peripheral leukocytes. Br J Cancer (2014) 0.79
Genome-wide identification of possible methylation markers chemosensitive to targeted regimens in colorectal cancers. J Cancer Res Clin Oncol (2011) 0.78
Recent developments in the clinical pharmacology of classical cytotoxic chemotherapy. Br J Clin Pharmacol (2006) 0.77
Identifying Significant Features in Cancer Methylation Data Using Gene Pathway Segmentation. Cancer Inform (2016) 0.75
DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet (2006) 18.08
Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics (2004) 2.79
Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res (2002) 2.34
Statistical process control for large scale microarray experiments. Bioinformatics (2002) 1.42
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. Cancer Res (2005) 1.34
Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. Eur J Endocrinol (2012) 1.18
DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. Clin Cancer Res (2009) 1.12
IL-10 is excluded from the functional cytokine memory of human CD4+ memory T lymphocytes. J Immunol (2007) 1.08
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis. J Urol (2007) 1.08
Replacement by a lacZ reporter gene assigns mouse connexin36, 45 and 43 to distinct cell types in pancreatic islets. Exp Cell Res (2004) 1.06
Connexin43-dependent mechanism modulates renin secretion and hypertension. J Clin Invest (2006) 1.00
Comparative DNA methylation analysis in normal and tumour tissues and in cancer cell lines using differential methylation hybridisation. Int J Biochem Cell Biol (2007) 0.92
Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytes. PLoS One (2012) 0.85
Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD). Nephrol Dial Transplant (2012) 0.83
ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy. Diabetes (2013) 0.81
Third Santorini conference pharmacogenomics workshop report: "Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?". Clin Chem Lab Med (2007) 0.78
Assessing the heterogeneity of in silico plasmid predictions based on whole-genome-sequenced clinical isolates. Brief Bioinform (2017) 0.75
Comparing genome versus proteome-based identification of clinical bacterial isolates. Brief Bioinform (2016) 0.75
Building the bridge between molecular diagnostics and therapeutics. Expert Rev Mol Diagn (2003) 0.75